Karyopharm Therapeutics I... (KPTI)
NASDAQ: KPTI
· Real-Time Price · USD
7.29
0.53 (7.84%)
At close: May 02, 2025, 3:59 PM
7.36
1.03%
After-hours: May 02, 2025, 04:05 PM EDT
Karyopharm Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
54
Upside
641.25
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Baird | Buy | Maintains | 75 54 | 641.25% | Mar 3, 2025 | |
| HC Wainwright & Co. | Strong Buy | Maintains | 7 56 | 668.70% | Feb 26, 2025 | |
| RBC Capital | Buy | Initiates | 45 45 | 517.71% | Feb 20, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.